Jinhai International Group Holdings (HKG:2225) unit Jinhai Technology Development (Shanghai) will inject a total of 16.5 million yuan by way of a cash contribution into Shanghai Lichen Medical Technology, a Monday bourse filing said.
Following the capital injection and the increase in Shanghai Lichen Medical Technology's registered capital, Jinhai Technology Development (Shanghai) will own a 55% stake in the former.
The remaining 45% stake will remain held by He Xiao, who is currently the sole shareholder of the medical device and equipment seller.
Jinhai International Group expects to integrate Shanghai Lichen Medical Technology's business activities into its existing business of minimally invasive surgery solution and medical product and related service provision.
Shares of the manpower services provider closed over 1% lower on Monday.
Price (HKD): $4.73, Change: $-0.07, Percent Change: -1.46%
Comments